CompaniesArpida

Arpida

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

3

As Collaborator

0

Total Enrollment

135

By Phase

PHASE2: 1PHASE3: 2

By Status

COMPLETED: 2TERMINATED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT00303550
Hover over trial bars to see details

Recent Trials

NCT00543608Lead Sponsor
Clinical Efficacy of Intravenous Iclaprim Versus Vancomycin in the Treatment of Hospital-Acquired, Ventilator-Associated, or Health-Care-Associated Pneumonia
PHASE2Terminated
135 participants
Started: Nov 30, 2007 · Completed: May 31, 2009
NCT00303550Lead Sponsor
Study of Intravenous (I.V.) Iclaprim Versus Linezolid in Complicated Skin and Skin Structure Infections [cSSSI] (ASSIST-2)
PHASE3Completed
Started: Mar 31, 2006
NCT00299520Lead Sponsor
Phase 3 Safety and Efficacy Study of I.V. Iclaprim v Linezolid in cSSSI (ASSIST-1)
PHASE3Completed
Started: Jun 30, 2005 · Completed: Jul 31, 2006
Related Companies
Evolva
acquired